Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
169 participants
INTERVENTIONAL
2010-07-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stent
Stent insertion into the main pancreatic duct
Stent insertion into the main pancreatic duct
Stent insertion into the main pancreatic duct
No stent
No stent insertion into the main pancreatic duct
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stent insertion into the main pancreatic duct
Stent insertion into the main pancreatic duct
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 17 years
* signed informed consent
Exclusion Criteria
* age \< 18 years
* pregnancy
* absent of signed informed consent
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northern State University, Russia
UNKNOWN
KU Leuven
OTHER
Latvijas Universitates Medicinas
UNKNOWN
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Monther Bajbouj
PD Dr. med. Hana Algül
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hana Algül, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
II. Medizinische Klinik, Klinikum rechts der Isar, Ismaniger Strasse 22, 81675 Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deptartment of Hepatobiliary Diseases Leuven University Hospitals
Leuven, , Belgium
Klinikum rechts der Isar, Technische Universität München
Munich, , Germany
P. Stradin Clinical University Hospital Gastroenterology Centere Latvijas Universitates Medicinas
Riga, , Latvia
First city hospital of emergency care Northern State Medical University
Arkhangelsk, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
240179
Identifier Type: -
Identifier Source: org_study_id